The management of coagulation disorders has been greatly assisted by the availability of suitable concentrates of blood coagulation factors, and the prompt institution of replacement therapy, for bleeding episodes, has resulted in substantial benefits to the patient with reduction in pain and disability (Green and Smith, 1972) . The establishment of haemophilia reference centres for the diagnosis and treatment of coagulation disorders, as initially advocated by the Medical Research Council in 1955, has facilitated the realization of the above aim. The importance of such centres has been emphasized subsequently (MacFarlane and Biggs, 1966; Dalrymple-Champneys et al, 1967; Rizza, 1970 (table IV) , assuming that one factor VIII unit is the amount of factor VIII in 1 ml of fresh pooled plasma.
Discussion
The prevalence of haemophilia A in the south-east of Scotland, 6 per 100 000 of the population, was higher than the estimated 3-4 per 100 000 for the population of Britain as a whole (MacFarlane, 1966) . Also, unexpectedly large numbers of patients with haemophilia B were registered in the south-east of Scotland, the relative frequency of haemophilia A to haemophilia B being 5: 1. This ratio differs markedly from that of 10:1 given by MacFarlane (1966) (1966) and Trueta (1966) , haemarthrosis of the knee joint was the most common while the hip joint was rarely affected. When bleeding occurred from a source other than a joint, the patient was more likely to be admitted. 
